The degree of bone marrow fibrosis in chronic myelogenous leukemia is not a prognostic factor with imatinib mesylate therapy

Hagop M. Kantarjian, Carlos E. Bueso-Ramos, Moshe Talpaz, Susan O'Brien, Francis Giles, Mary Beth Rios, Jianqin Shan, Jorge Cortes

Research output: Contribution to journal › Article › peer-review